Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Connect Twitter with Market Wire News

ORMP - Oramed Pharmaceuticals Stock Trading


home / stock / ormp

ORMP ORMP Quote ORMP Short ORMP News ORMP Articles ORMP Message Board

About | Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)

Oramed Pharmaceuticals OTC:ORMP.OB is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an oral insulin capsule currently in Phase trials, the Company is seeking to revolutionize the treatment of diabetes.

Quote | Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)

Last:$3.96
Change Percent: -3.83%
Open:$3.8
Close:$3.96
High:$4.05
Low:$3.65
Volume:633,520
Last Trade Date Time:05/26/2023 03:00:00 am

News | Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)

  • Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit

    Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit PR Newswire NEW YORK , May 18, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: O...

    • May 18, 2023 07:55:00 am
    • |
    • PR Newswire
    • |
      • ORMP Stock
      • ORMP Quote
      • ORMP Short
      • ORMP News
      • ORMP Articles
      • ORMP Message Board
  • Oramed: Buyer Beware

    2023-05-16 21:04:48 ET Summary On May 15, Oramed announced that their partner in China had completed a positive phase 3 oral insulin trial in China and had submitted an application to the Chinese regulator. In the same PR, Oramed announced their post-hoc analysis of their failed U...

    • May 16, 2023 09:04:48 pm
    • |
    • SeekingAlpha
    • |
      • ORMP Stock
      • ORMP Quote
      • ORMP Short
      • ORMP News
      • ORMP Articles
      • ORMP Message Board

Message Board Posts | Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)

Subject By Source When
I agree - I will be happy if Amatuer17 investorshub 05/15/2023 2:49:52 PM
I am completely out of this stock midastouch017 investorshub 05/15/2023 2:42:47 PM
That is good news for Oramed - not Amatuer17 investorshub 05/15/2023 2:38:29 PM
3.8200+0.9900 (+34.9823%) midastouch017 investorshub 05/15/2023 1:51:05 PM
Oramed Announces that its Chinese Partner, HTIT, has midastouch017 investorshub 05/15/2023 1:22:47 PM
Stock Information

Oramed Pharmaceuticals Inc. Company Name:

ORMP Stock Symbol:

NASDAQ Market:

Oramed Pharmaceuticals Inc. Website:

Oramed Pharmaceuticals Inc. Logo

Get ORMP Alerts

News, Short Squeeze, Breakout and More Instantly...

Ad

Connect Twitter with Market Wire News
RECENT ORMP NEWS
  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Coins
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Join us on Discord

Join us on Discord

Follow us on discord to get immediate notifications!

Check out the New Market Wire News Discord Bot

Discord


Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

Follow @marketwirenews

| Facebook

| Telegram

| LinkedIn

| Reddit

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2023 Market Wire News